Cargando…
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
BACKGROUND: Few studies, if any, have examined cardiovascular outcomes in patients with diabetes and gout. Both diabetes and gout are risk factors for cardiovascular disease. The objective of this study was to examine the effect of allopurinol on the risk of incident acute cardiovascular events in p...
Autores principales: | Singh, Jasvinder A., Ramachandaran, Rekha, Yu, Shaohua, Curtis, Jeffrey R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348884/ https://www.ncbi.nlm.nih.gov/pubmed/28288564 http://dx.doi.org/10.1186/s12872-017-0513-6 |
Ejemplares similares
-
Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study
por: Singh, Jasvinder A., et al.
Publicado: (2017) -
Allopurinol and the risk of stroke in older adults receiving medicare
por: Singh, Jasvinder A., et al.
Publicado: (2016) -
Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
por: Kang, Eun Ha, et al.
Publicado: (2021) -
Cardiovascular risk associated with allopurinol or benzbromarone
treatment in patients with gout
por: Eun, Yeonghee, et al.
Publicado: (2022) -
Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims
por: Singh, Jasvinder A., et al.
Publicado: (2016)